Molecular Characterization of Pseudomonas putida Group Isolates Carrying blaVIM-2 Disseminated in a University Hospital in Korea

Jun Sung Hong, Eun Jeong Yoon, Wonkeun Song, Yu Bin Seo, Saeam Shin, Min Jeong Park, Seokhoon Jeong, Kyungwon Lee

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Pseudomonas putida group are Gram-negative bacilli with polar flagellation, which are ubiquitous in the environment, although they are rarely involved in human infections. The aim of this study was to identify the dissemination of VIM-2-producing P. putida group in clinical isolates from a hospital in Korea. Thirteen strains were collected from 2014 to 2015 for the study. The isolates were recovered from urine cultures of both inpatients and outpatients at the hospital. Minimum inhibitory concentrations of antibiotics were determined by Etest. Carbapenemase genes were amplified by polymerase chain reaction and sequenced. Pulsed-field gel electrophoresis was performed for strain typing. Whole-genome sequencing was carried out randomly for two strains chosen from each year of the study to analyze the plasmid structure carrying the blaVIM-2 genes. The 13 isolates carried nine different class I integrons harboring VIM-2 and were resistant to meropenem and imipenem (minimum inhibitory concentrations, ≥32 μg/ml), thus exhibiting a multidrug-resistant phenotype. The blaVIM-2 gene was located on a plasmid in seven of the isolates and on the chromosome in six isolates. Each case of the blaVIM-2 gene was disseminated by clonal spread, horizontal transfer, and was mostly an occasional occurrence. In this study, we demonstrated that multidrug-resistant P. putida group carrying VIM-2 has reemerged in human specimens in Korea.

Original languageEnglish
Pages (from-to)627-634
Number of pages8
JournalMicrobial Drug Resistance
Volume24
Issue number5
DOIs
Publication statusPublished - 2018 Jun 1

Fingerprint

Pseudomonas putida
Korea
meropenem
Microbial Sensitivity Tests
Genes
Plasmids
Disk Diffusion Antimicrobial Tests
Integrons
Imipenem
Pulsed Field Gel Electrophoresis
Bacillus
Inpatients
Outpatients
Chromosomes
Urine
Genome
Anti-Bacterial Agents
Phenotype
Polymerase Chain Reaction
Infection

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Immunology
  • Pharmacology
  • Microbiology (medical)

Cite this

Hong, Jun Sung ; Yoon, Eun Jeong ; Song, Wonkeun ; Seo, Yu Bin ; Shin, Saeam ; Park, Min Jeong ; Jeong, Seokhoon ; Lee, Kyungwon. / Molecular Characterization of Pseudomonas putida Group Isolates Carrying blaVIM-2 Disseminated in a University Hospital in Korea. In: Microbial Drug Resistance. 2018 ; Vol. 24, No. 5. pp. 627-634.
@article{0aeeb43da27c4d7fbb1c4f8900bc6ff2,
title = "Molecular Characterization of Pseudomonas putida Group Isolates Carrying blaVIM-2 Disseminated in a University Hospital in Korea",
abstract = "Pseudomonas putida group are Gram-negative bacilli with polar flagellation, which are ubiquitous in the environment, although they are rarely involved in human infections. The aim of this study was to identify the dissemination of VIM-2-producing P. putida group in clinical isolates from a hospital in Korea. Thirteen strains were collected from 2014 to 2015 for the study. The isolates were recovered from urine cultures of both inpatients and outpatients at the hospital. Minimum inhibitory concentrations of antibiotics were determined by Etest. Carbapenemase genes were amplified by polymerase chain reaction and sequenced. Pulsed-field gel electrophoresis was performed for strain typing. Whole-genome sequencing was carried out randomly for two strains chosen from each year of the study to analyze the plasmid structure carrying the blaVIM-2 genes. The 13 isolates carried nine different class I integrons harboring VIM-2 and were resistant to meropenem and imipenem (minimum inhibitory concentrations, ≥32 μg/ml), thus exhibiting a multidrug-resistant phenotype. The blaVIM-2 gene was located on a plasmid in seven of the isolates and on the chromosome in six isolates. Each case of the blaVIM-2 gene was disseminated by clonal spread, horizontal transfer, and was mostly an occasional occurrence. In this study, we demonstrated that multidrug-resistant P. putida group carrying VIM-2 has reemerged in human specimens in Korea.",
author = "Hong, {Jun Sung} and Yoon, {Eun Jeong} and Wonkeun Song and Seo, {Yu Bin} and Saeam Shin and Park, {Min Jeong} and Seokhoon Jeong and Kyungwon Lee",
year = "2018",
month = "6",
day = "1",
doi = "10.1089/mdr.2017.0257",
language = "English",
volume = "24",
pages = "627--634",
journal = "Microbial Drug Resistance",
issn = "1076-6294",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

Molecular Characterization of Pseudomonas putida Group Isolates Carrying blaVIM-2 Disseminated in a University Hospital in Korea. / Hong, Jun Sung; Yoon, Eun Jeong; Song, Wonkeun; Seo, Yu Bin; Shin, Saeam; Park, Min Jeong; Jeong, Seokhoon; Lee, Kyungwon.

In: Microbial Drug Resistance, Vol. 24, No. 5, 01.06.2018, p. 627-634.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Molecular Characterization of Pseudomonas putida Group Isolates Carrying blaVIM-2 Disseminated in a University Hospital in Korea

AU - Hong, Jun Sung

AU - Yoon, Eun Jeong

AU - Song, Wonkeun

AU - Seo, Yu Bin

AU - Shin, Saeam

AU - Park, Min Jeong

AU - Jeong, Seokhoon

AU - Lee, Kyungwon

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Pseudomonas putida group are Gram-negative bacilli with polar flagellation, which are ubiquitous in the environment, although they are rarely involved in human infections. The aim of this study was to identify the dissemination of VIM-2-producing P. putida group in clinical isolates from a hospital in Korea. Thirteen strains were collected from 2014 to 2015 for the study. The isolates were recovered from urine cultures of both inpatients and outpatients at the hospital. Minimum inhibitory concentrations of antibiotics were determined by Etest. Carbapenemase genes were amplified by polymerase chain reaction and sequenced. Pulsed-field gel electrophoresis was performed for strain typing. Whole-genome sequencing was carried out randomly for two strains chosen from each year of the study to analyze the plasmid structure carrying the blaVIM-2 genes. The 13 isolates carried nine different class I integrons harboring VIM-2 and were resistant to meropenem and imipenem (minimum inhibitory concentrations, ≥32 μg/ml), thus exhibiting a multidrug-resistant phenotype. The blaVIM-2 gene was located on a plasmid in seven of the isolates and on the chromosome in six isolates. Each case of the blaVIM-2 gene was disseminated by clonal spread, horizontal transfer, and was mostly an occasional occurrence. In this study, we demonstrated that multidrug-resistant P. putida group carrying VIM-2 has reemerged in human specimens in Korea.

AB - Pseudomonas putida group are Gram-negative bacilli with polar flagellation, which are ubiquitous in the environment, although they are rarely involved in human infections. The aim of this study was to identify the dissemination of VIM-2-producing P. putida group in clinical isolates from a hospital in Korea. Thirteen strains were collected from 2014 to 2015 for the study. The isolates were recovered from urine cultures of both inpatients and outpatients at the hospital. Minimum inhibitory concentrations of antibiotics were determined by Etest. Carbapenemase genes were amplified by polymerase chain reaction and sequenced. Pulsed-field gel electrophoresis was performed for strain typing. Whole-genome sequencing was carried out randomly for two strains chosen from each year of the study to analyze the plasmid structure carrying the blaVIM-2 genes. The 13 isolates carried nine different class I integrons harboring VIM-2 and were resistant to meropenem and imipenem (minimum inhibitory concentrations, ≥32 μg/ml), thus exhibiting a multidrug-resistant phenotype. The blaVIM-2 gene was located on a plasmid in seven of the isolates and on the chromosome in six isolates. Each case of the blaVIM-2 gene was disseminated by clonal spread, horizontal transfer, and was mostly an occasional occurrence. In this study, we demonstrated that multidrug-resistant P. putida group carrying VIM-2 has reemerged in human specimens in Korea.

UR - http://www.scopus.com/inward/record.url?scp=85048061479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048061479&partnerID=8YFLogxK

U2 - 10.1089/mdr.2017.0257

DO - 10.1089/mdr.2017.0257

M3 - Article

VL - 24

SP - 627

EP - 634

JO - Microbial Drug Resistance

JF - Microbial Drug Resistance

SN - 1076-6294

IS - 5

ER -